Mast Therapeutics' IPO

Mast Therapeutics raised a round of funding on September 09, 2004. Investors include Public.

Mast Therapeutics (NYSEMKT: MSTX), fka ADVENTRX Pharmaceuticals, is a biopharmaceutical company focused on in-licensing, developing, and commercializing proprietary product candidates primarily for th…

Articles about Mast Therapeutics' IPO: